First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index; none of the 46 sources its claims cite is checked for support yet.
Abstract
Paracetamol is arguably the most commonly used analgesic and antipyretic drug worldwide, however its mechanism of action is still not fully established. It has been shown to exert effects through multiple pathways, some actions suggested to be mediated via N-arachidonoylphenolamine (AM404). AM404, formed through conjugation of paracetamol-derived p-aminophenol with arachidonic acid in the brain, is an activator of the capsaicin receptor, TRPV1, and inhibits the reuptake of the endocannabinoid, anandamide, into postsynaptic neurons, as well as inhibiting synthesis of PGE 2 by COX-2. However, the presence of AM404 in the central nervous system following administration of paracetamol has not yet been demonstrated in humans. Cerebrospinal fluid (CSF) and blood were collected from 26 adult male patients between 10 and 211 minutes following intravenous administration of 1 g of paracetamol. Paracetamol was measured by high-performance liquid chromatography with UV detection. AM404 was measured by liquid chromatography-tandem mass spectrometry. AM404 was detected in 17 of the 26 evaluable CSF samples at 5–40 nmol⋅L –1 . Paracetamol was measurable in CSF within 10 minutes, with a maximum measured concentration of 60 μmol⋅L –1 at 206 minutes. This study is the first to report on the presence of AM404 in human CSF following paracetamol administration. This may represent an important finding in our understanding of paracetamol’s mechanism of action, although measured concentrations were far below the previously documented IC50 for this metabolite. Keywords: acetaminophen, paracetamol, paracetamol: mechanism of action, AM404, N-arachidonoylphenolamine, pharmacology - theories of analgesic action
Overview
CoChat Summary
TL;DR
In 26 adult male patients undergoing spinal anesthesia, intravenous 1 g paracetamol produced detectable AM404 in human CSF for the first time, with AM404 found in 17 of 26 evaluable CSF samples. Measured AM404 concentrations were far below previously documented IC50 values, so the clinical relevance remains unclear.
Key findings
- AM404 was detected in 17 of 26 evaluable CSF samples from 10 minutes post-administration; 14 were above the reliable quantitation limit of 5 nmol·L−1, mostly ranging 5.1–57.4 nmol·L−1, with one anomalous measurement of 166.8 nmol·L−1.
- Paracetamol was measurable in CSF within 10 minutes at 5 μmol·L−1, with a maximal measured CSF concentration of 99 μmol·L−1; plasma paracetamol ranged from 92 to 506 μmol·L−1.
- AM404 was detectable in only 8 of 26 plasma samples, with three above the limit of quantitation (>5 nmol·L−1), ranging 6.1–65.4 nmol·L−1.
- Measured AM404 concentrations in CSF did not correlate with time of collection.
Methods
- Pilot study: 30 ASA I–III adult male and female patients aged 18–80 years scheduled for elective urological surgery under spinal anesthesia were recruited; after exclusions, 26 male patients were analyzed. Patients received a single intravenous 1 g paracetamol infusion over 10 minutes and were randomized to sample collection at 15, 30, or 120 minutes post-infusion.
- CSF (5 mL) and blood (10 mL) were collected at lumbar puncture before intrathecal local anesthetic; samples were stored on ice, centrifuged, and frozen at −20°C until analysis.
- Paracetamol was measured by HPLC with UV detection; AM404 was measured by LC-MS/MS. The study reports measured concentrations and examined whether CSF AM404 correlated with collection time.
Limitations
- Stated: the exact pathway and clinical relevance of AM404 in humans remain unclear; evidence for AM404 comes largely from animal studies; measured concentrations were far below the previously documented IC50 for this metabolite, and IC50/EC50 values have not been measured in human CSF.
- Stated: CSF AM404 concentrations may significantly underestimate brain concentrations in FAAH-rich areas; the study does not report pharmacokinetic modeling; sample collection times were not precise because of operating theater schedules.
- Evident: this is a small pilot study with only 26 male patients analyzed (only three female patients were recruited, and four patients were excluded), using a single 1 g intravenous dose and no clinical outcome measures; masking was not carried out, though the authors state clinical bias was not a concern.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
0 Valid · 1 Not valid · 22 Not checked · 14 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Measured AM404 concentrations in CSF did not correlate with time of collection”
- Also stated in: § CSF and plasma sample analyses · plain
“Measured AM404 concentrations in CSF did not correlate with time of collection (Figure 2).”
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Results > CSF and plasma sample analyses
plainn = 26- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § CSF and plasma sample analyses · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“14 of these were above the level of reliable quantitation of 5 nmol⋅L−1, ranging mostly from 5.1 to 57.4 nmol⋅L−1 with one anomalous measurement of 166.8 nmol⋅L−1.”
- Also stated in: § Discussion · plain
“AM404, a putatively active metabolite of paracetamol and apparent intermediary in several analgesic pathways in animal models,7,10,15 was measured in CSF in 14 of 26 patients at concentrations of 5.1–57.4 nmol⋅L−1 with an outlier at 166.8 nmol⋅L−1”
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Results > CSF and plasma sample analyses
plainn = 26- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“AM404 was detected in 17 of the 26 evaluable CSF samples at 5–40 nmol⋅L−1.”
- Also stated in: § CSF and plasma sample analyses · plain
“AM404 was detected in 17 of the 26 evaluable CSF samples from 10 minutes post-administration; 14 of these were above the level of reliable quantitation of 5 nmol⋅L−1, ranging mostly from 5.1 to 57.4 nmol⋅L−1 with one anomalous measurement of 166.8 nmol⋅L−1.”
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Abstract
plainstates a causen = 26- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § CSF and plasma sample analyses · plain
None of the sources cited for this claim have been checked yet.
In the paper
“although measured concentrations were far below the previously documented IC50 for this metabolite.”
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Abstract
What the sources say
- Not checked yetcites [9] Fu J Bottegoni G Sasso O A catalytically silent FAAH-1 variant drives anandamide transport in neurons Nat Neurosci 2011 15 1 64 69 22101642 PMC3245783
- Not checked yetcites [10] Högestätt ED Jönsson BA Ermund A Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system J Biol Chem 2005 280 36 31405 31412 15987694
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This study is the first to report on the presence of AM404 in human CSF following paracetamol administration.”
- Also stated in: § Discussion · plain
“The current study is the first to report on the presence of AM404 in human CSF and plasma samples following intravenous administration of 1 g paracetamol.”
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Abstract
plainstates a causen = 26- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Discussion · plain
3 more claims
Create a free account to see all 37 claims and to verify the 46 references still open.
- It may state two separate claims as one. 17
- The quote only partly states this claim. 1
- Borderline: one of the tests for a substantial claim is unclear. 1
- Probably not a substantial claim. 22
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The first human evidence of central conversion of paracetamol to AM404 was demonstrated by Sharma et al in 2017; 26 patients received 1g of paracetamol, followed by measurement of the AM404 in the cerebrospinal fluid (CSF) and blood. The study detected AM404 in the CSF of 17 patients, confirming the central conversion of paracetamol to the bioactive AM404 in humans.43”
From An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact (2023) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We were the first to report on the presence of AM404 in human CSF and plasma samples following intravenous administration of 1 g paracetamol (in CSF samples of 14 of 26 patients at concentrations of 5.1-57.4nmol.L -1 ) [101].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [101]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“AM404 has been demonstrated in in vitro studies to inhibit reuptake of anandamide, block TRPV1 and inhibit COX-1 and COX-2 activities [86,98,[102][103][104][105] in the high nanomolar to low micromolar concentration range, well above the concentrations were able to detect in human CSF [101].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Methods > Measurement of AM404 in CSF and plasma
“The limits of quantitation for AM404 in CSF and plasma were 0.5 nmol⋅L−1 and 5 nmol⋅L−1, respectively (S/N=10).”
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Results > CSF and plasma sample analyses
“14 of these were above the level of reliable quantitation of 5 nmol⋅L−1”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Abstract
“Paracetamol was measurable in CSF within 10 minutes, with a maximum measured concentration of 60 μmol⋅L−1 at 206 minutes.”
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Results > CSF and plasma sample analyses
“Paracetamol was detectable in CSF at 10 minutes at 5 μmol⋅L−1, and at a maximal measured concentration of 99 μmol⋅L−1.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Introduction
“AM404 is also an activator of TRPV1, otherwise known as the capsaicin receptor.”
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Discussion
“AM404 has been demonstrated in in vitro studies to inhibit reuptake of anandamide,9,10,15,16 TRPV1 receptor activity,10,11 and PGE2 production via COX-1 and COX-2,10”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Abstract
“AM404 was detected in 17 of the 26 evaluable CSF samples at 5–40 nmol⋅L−1.”
§ First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid > Results > CSF and plasma sample analyses
“14 of these were above the level of reliable quantitation of 5 nmol⋅L−1, ranging mostly from 5.1 to 57.4 nmol⋅L−1 with one anomalous measurement of 166.8 nmol⋅L−1.”
Citations
Cites
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
FLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779 · cited 1×
“1,2,20,21 These in vitro and in vivo experiments consistently demonstrated reduction of brain and spinal cord prostaglandin synthesis, which is likely to be an action either directly of paracetamol or through AM404.”
Randomization and allocation concealment: a practical guide for researchers
Doig, G. S., & Simpson, F. (2005) · Journal of Critical Care · doi:10.1016/j.jcrc.2005.04.005 · Cited by 656
Högestätt, E. D., Jönsson, B. A. G., Ermund, A., Andersson, D. A., Björk, H., Alexander, J. P., Cravatt, B. F., Basbaum, A. I., & Zygmunt, P. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501489200 · Cited by 454
Analgesic effect of acetaminophen in humans: First evidence of a central serotonergic mechanism
PICKERING, G., LORIOT, M., LIBERT, F., ESCHALIER, A., BEAUNE, P., & DUBRAY, C. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.12.307 · Cited by 283
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors
Ottani, A., Leone, S., Sandrini, M., Ferrari, A., & Bertolini, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.015 · Cited by 279
The anandamide transport inhibitor AM404 activates vanilloid receptors
Zygmunt, P. M., Chuang, H.-H., Movahed, P., Julius, D., & Högestätt, E. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00207-7 · Cited by 270 · cited 1×
“The consequence of this is increased AEA within the synaptic cleft, producing increased cannabinoid receptor (CB 1 ) activation.(10,11) AM404 is also an activator of TRPV1, otherwise known as the capsaicin receptor.”
Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology
Giuffrida, A., Beltramo, M., & Piomelli, D. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29345-9 · Cited by 226
Singla, N. K., Parulan, C., Samson, R., Hutchinson, J., Bushnell, R., Beja, E. G., Ang, R., & Royal, M. A. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00556.x · Cited by 224
Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia
Mallet, C., Daulhac, L., Bonnefont, J., Ledent, C., Etienne, M., Chapuy, E., Libert, F., & Eschalier, A. (2008) · Pain · doi:10.1016/j.pain.2008.03.030 · Cited by 223
Cited by
New approaches and challenges to targeting the endocannabinoid system
Di Marzo, V. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.115 · Cited by 480
Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
Ayoub, S. S. (2021) · Temperature · doi:10.1080/23328940.2021.1886392 · Cited by 223
Self-citationParacetamol – An old drug with new mechanisms of action
Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190
Pinto, B., Morelli, G., Rastogi, M., Savardi, A., Fumagalli, A., Petretto, A., Bartolucci, M., Varea, E., Catelani, T., Contestabile, A., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.010 · Cited by 135
“In particular, literature suggests that it is not APAP tout-court but its metabolite AM404 that is able to inhibit microglial activation (Sharma et al., 2017).”
BackgroundA Guide to Targeting the Endocannabinoid System in Drug Design
Stasiulewicz, A., Znajdek, K., Grudzień, M., Pawiński, T., & Sulkowska, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082778 · Cited by 108
Metadata
- Authors
- Sharma, C., Long, J. H., Shah, S., Rahman, J., Perrett, D., Ayoub, S., & Mehta, V.
- Affiliations
- St Bartholomew's Hospital (GB)
- Queen Mary University of London (GB)
- University of East London (GB)
- Corresponding author
- Sharma, Chhaya
- Venue
- Journal of Pain Research
- Publisher
- Informa UK Limited
- Published
- 2017-11
- Volume
- Volume 10
- Pages
- 2703-2709
- ISSN
- 1178-7090 (ISSN-L)
- PMC
- PMC5716395
- OpenAlex
- W2769311760
- Cited by
- 51
- References
- 23
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 5 · 2018: 6
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Pain Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UEL Research Repository (University of East London) (acceptedVersion)
- UEL Research Repository (University of East London) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- UEL Research Repository (University of East London) (submittedVersion, cc-by-nc)
- Funders
- American Pain Society
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- paracetamol, AM404, cerebrospinal fluid, drug metabolism, 4-aminophenol, TRPV1, cyclooxygenase-2, intravenous administration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid. https://app.cochat.ai/papers/10.2147/jpr.s143500
- The paper
- Sharma, C., Long, J. H., Shah, S., Rahman, J., Perrett, D., Ayoub, S., & Mehta, V. (2017). First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid. Journal of Pain Research. https://doi.org/10.2147/jpr.s143500
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.